Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy. The price is a significant premium on the $5.5 bn ...

A key consumer survey showed a fall in household sentiment in March, adding to evidence that people are taking a more negative view of the economy. The Conference Board’s monthly survey showed ...

BMS plans to separate its R&D into early- and late-stage divisions, with Celgene’s Rupert Vessey earmarked to lead the former and new recruit Samit Hirawat – formerly head of oncology R&D of ...

Optimism among individual investors about the short-term outlook for stocks increased in the latest AAII Sentiment Survey. Meanwhile, neutral sentiment and pessimism decreased. Bullish sentiment, ...